IceCure Medical Ltd entered into a sales agreement with A.G.P./Alliance Global Partners to issue and sell up to $4,339,697 of ordinary shares through an at-the-market offering pursuant to an effective Form F-3 registration statement.
Key takeaways
Entered Sales Agreement dated May 12, 2026 with A.G.P./Alliance Global Partners for ATM offering.
Up to $4,339,697 of ordinary shares (no par value) authorized for sale from time to time.
Sales to be effected via Placement Notices specifying shares, period, daily limits, and minimum price.
Sullivan & Worcester Tel-Aviv provided legal opinion confirming validity of Placement Shares upon issuance.
Filed prospectus supplement under shelf Registration Statement (File No. 333-290046) on Form F-3.
Sales Agent to receive compensation per Schedule 3; no obligation to sell unless Placement Notice accepted.